This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Alexander Knaupp: Patent Activity in Antibody Research
Introduction
Alexander Knaupp is an inventor associated with Wackersberg, Germany. His recorded patent concerns antibodies that bind to CD3 and FOLR1, targets relevant to biomedical research.
Latest Patents
Knaupp is listed as an inventor on 1 patent: “Antibodies Binding to CD3 and FOLR1.” The patent describes antibodies that bind to both CD3 and FOLR1.
Career Highlights
Knaupp is associated with Roche Diagnostics GmbH. His listed patent reflects work in antibody-related research and development.
Collaborations
Knaupp’s listed coworkers include Peter Bruenker and Martina Geiger.
Conclusion
Alexander Knaupp’s recorded invention connects his work at Roche Diagnostics GmbH with research into antibodies binding to CD3 and FOLR1.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile